Tianjin TEDA Biomedical Engineering Company Limited announced that at its special general meeting held on February 8, 2022, shareholders approved the appointment of Mr. Zhao Zhiyou as the independent supervisor of the company for a term commencing from the date of passing this resolution and ending upon the conclusion of the seventh session of the Supervisory Committee.
Tianjin TEDA Biomedical Engineering Company Limited
Equities
8189
CNE1000004H7
Agricultural Chemicals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.076 HKD | -2.56% | +2.70% | -14.61% |
1st Jan change | Capi. | |
---|---|---|
-14.61% | 18.92M | |
-19.10% | 13.96B | |
-5.89% | 13.68B | |
+11.85% | 13.26B | |
-15.45% | 9.71B | |
-11.71% | 7.58B | |
-.--% | 7.4B | |
-12.46% | 5.88B | |
-0.34% | 4.36B | |
-25.04% | 2.5B |
- Stock Market
- Equities
- 8189 Stock
- News Tianjin TEDA Biomedical Engineering Company Limited
- Tianjin TEDA Biomedical Engineering Company Limited Approves Appointment of Mr. Zhao Zhiyou as the Independent Supervisor